Canton Nuleic Acids Forum _ Academic conference Online

2026年传感器技术、自动化与智能制造国际会议（STAIM 2026）

第三届图像处理、多媒体技术与机器学习国际学术会议（IPMML 2026）

2026年智能医学与图像计算国际会议 (IMIC 2026)

2026年具身智能、机器人与控制系统国际学术会议（EIRCS 2026）

第五届信息经济、数据建模与云计算国际学术会议（ICIDC 2026）

第三届数字媒体、通信与信息系统国际学术会议（DMCIS 2026）

2026年智能机器人与控制技术国际会议（CIRCT 2026）

第五届机械电子工程与人工智能国际学术会议（MEAI 2026）

第六届先进制造技术与电子信息国际学术会议（AMTEI 2026）

第三届大数据、神经网络与深度学习研讨会（BDNNDL 2026）

第十一届计算机与信息处理技术国际学术研讨会（ISCIPT 2026）

第六届计算机视觉、应用与算法国际学术会议（CVAA 2026）

2026年IEEE计算机通信、信息系统与网络安全国际会议(CCISC 2026)

第八届能源、电力与电网国际学术会议（ICEPG 2026）

2026年第五届算法、数据挖掘和信息技术国际会议(ADMIT 2026)

2026年人工智能与机器人系统国际会议(ICAIRS 2026)

第四届人工智能与自动化控制国际学术会议（AIAC 2026）

2026年IEEE人工智能、大数据与云计算国际会议 (AIBDCC 2026)

第八届信息与计算机前沿技术国际学术会议（ICFTIC 2026）

2026年IEEE第二届电力与可持续能源技术国际会议(PSETC 2026)

Meetings: 37943

Canton Nuleic Acids Forum 2016-11-9 venue:广州市

Nucleic acids science is a cutting-edge research field, which is slated to play a key role in precision medicine and new solutions for human health. Continuous discovery of new RNA functions and constant emergence of innovative nucleic acids technologies are driving forces for the field and hold enormous promise for the future scientific and technological progress. The Canton Nucleic Acids Forum (CNAF) is at the forefront of these developments, having held three successful conferences in 2013-2015. The events have attracted high-profile speakers, led by Nobel prize winners, prominent international scientists and industry leaders, providing a high-level platform for sharing recent discoveries by scientists and entrepreneurs. The CNAF is now widely recognized as a premier forum in the field of nucleic acids research and development in China and beyond. We are currently preparing the fourth – CNAF ’16 – event, which promises to be another outstanding gathering of scientists and experts from many countries.

CNAF'16：http://www.cnaf.org.cn/index_enzc.html

Confirmed speakers:

Howard CHANG, MD, PhD
Professor, Stanford University, USA
Howard Hughes Medical Institute
Muthiah MANOHARAN, PhD
Senior Vice President, Drug Discovery, Alnylam Pharmaceuticals, USA
Board Director, Oligonucleotide Therapeutics Society
Stanley CROOKE, MD, PhD
Founder, CEO and Chairman of the Board
Ionis Pharmaceuticals, USA
Craig MELLO, PhD
Professor, University of Massachusetts
Howard Hughes Medical Institute, USA
Nobel Prize in Physiology or Medicine (2006)
Mark EDBROOKE, PhD
Director, AstraZeneca, UK
Mikiko SIOMI, PhD
Professor, the University of Tokyo, Japan
Jan GORODKIN, PhD
Professor, University of Copenhagen
Director, Center for Non-Coding RNA
in Technology and Health, Denmark
William SKARNES, PhD
Senior Group Leader
Wellcome Trust Sanger Institute, UK
Chuan HE, PhD
Professor, University of Chicago, USA
Howard Hughes Medical Institute
Erik SONTHEIMER, PhD
Professor, University of Massachusetts
Medical School, USA
Robert HOLT, PhD
Professor, University of British Columbia, Canada
Jian-Sheng SUN, PhD, HDR
Professor, Muséum National d’Histoire Naturelle
MNHN-CNRS-INSERM, France
Jin-Soo KIM, PhD
Professor, Seoul National University
Director, Institute for Basic Science, South Korea
Elizabeth TRAN, PhD
Associate Professor
Purdue University, USA
Troels KOCH, PhD
VP and Head of Research, RNA Therapeutics
Roche, Denmark / Switzerland
Ada YONATH, PhD
Professor, Weizmann Institute of Science, Israel
Nobel Prize in Chemistry 2009
Ekkehard LEBERER, PhD
Professor, Senior Director, Sanofi, Germany
Founding Director, COMPACT Consortium
Yi-Tao YU, PhD
Professor, University of Rochester Medical Center
School of Medicine and Dentistry, USA
Judy LIEBERMAN, MD, PhD
Professor, Program Chair,
Harvard Medical School
American Academy of Arts & Sciences, USA

Conference website

重要会议推荐